pegasusnews.com
May 16, 2008
DALLAS — Dallas-based American Heart Association released a statement about cardiovascular evaluation and monitoring of children receiving drugs for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) on April 21, 2008. As a result of language in the news release and the statement as...
[read full story]